Novartis
NVS
#46
Rank
$209.65 B
Marketcap
$98.91
Share price
1.85%
Change (1 day)
10.16%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Cash on Hand

Cash on Hand as of March 2023 : $12.26 B

According to Novartis's latest financial reports the company has $12.26 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novartis - Cash on Hand chart (from 2001 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$18.61 B-33.79%
2021-12-31$28.11 B148.94%
2020-12-31$11.29 B-1.34%
2019-12-31$11.44 B-28.3%
2018-12-31$15.96 B68.31%
2017-12-31$9.48 B21.96%
2016-12-31$7.77 B42.78%
2015-12-31$5.44 B-60.71%
2014-12-31$13.86 B50.31%
2013-12-31$9.22 B13.59%
2012-12-31$8.11 B59.98%
2011-12-31$5.07 B-37.61%
2010-12-31$8.13 B-53.38%
2009-12-31$17.44 B185.25%
2008-12-31$6.11 B-53.66%
2007-12-31$13.20 B65.95%
2006-12-31$7.95 B-27.24%
2005-12-31$10.93 B-25.08%
2004-12-31$14.59 B10.06%
2003-12-31$13.25 B5.44%
2002-12-31$12.57 B-4.61%
2001-12-31$13.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$23.51 B 91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.73 B 85.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.17 B-17.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.35 B 17.06%๐Ÿ‡ซ๐Ÿ‡ท France
$13.19 B 7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.99 B-26.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.46 B-47.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
$8.64 B-29.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.80 B-77.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel